I am a subscriber to a newsletter by a former NASA flight surgeon. He was prescribed statins for high cholesterol a few years back. They ruined his health. He has great info on his site about statins, cholesterol and heart disease. The following is from a guest writer. VERY informative.
"The gigantic MONICA study, sponsored by the World Health Organization, analyzed the relation between cardiovascular mortality and blood cholesterol in 27 countries, in much the same way as the Seven Countries Study. The results are similar, showing that countries like Japan and China have low mortality and low cholesterol levels, and countries like Finland have high mortality and high cholesterol levels. 
Yet countries like France, Germany, Switzerland, and Luxembourg have a low mortality rate and yet a high blood cholesterol value. This so-called "French paradox" is not a paradox at all, when examination of the data reveals great disparities in mortality between different regions with the same cholesterol levels. 
Similarly the residents of Corfu have a 5 fold greater mortality than residents of Crete, despite identical dietary practices and identical cholesterol levels. Residents of the North Karelia regions of Finland have mortality rate of 493/100,000 and those in Fribourg France have mortality rate of 102/100,000, yet the cholesterol levels are identical at 245 mg/dl in both regions.
The National Cholesterol Education Program is a quasi-governmental body sponsored by members of the National Institutes of Health, American Heart Association, and other supporters of the "diet-heart" hypothesis. This body recommends a low fat, high carbohydrate diet to prevent heart disease, in spite of the increasing incidence of diabetes, obesity, and hypertension that is linked to consumers of this diet. 
They consistently advocate programs of extreme lowering of cholesterol levels by drug therapy, in spite of evidence of increased risk of mortality from heart failure, cancer, cirrhosis, and other diseases in older subjects with low cholesterol levels. They also recently recommended lowering the acceptable level of Low Density Lipoprotein (LDL) in the population by statin therapy, in spite of the fact that 8 of the 9 members of the advisory panel had a direct conflict of interest by accepting payments from the drug industry. 
This body has popularized the concept that LDL is "bad cholesterol" and HDL is "good cholesterol" in spite of the marginal and sometimes contradictory data distinguishing these fractions from total blood cholesterol. This body also advocates "aggressive cholesterol lowering" in the population in spite of the fact that no cholesterol lowering trials have demonstrated reduced mortality or sudden death from such treatments in the otherwise normal population.
Kilmer S. McCully, M.D."
http://spacedoc.net/kilmer_mccully_cholesterol_1
http://spacedoc.net/kilmer_mccully_cholesterol_2